CIBRA Capital's Big Bet on Amicus Therapeutics episode artwork

EPISODE · Apr 25, 2026 · 1 MIN

CIBRA Capital's Big Bet on Amicus Therapeutics

from The Daily News Now! Business

CIBRA Capitals latest SEC filing reveals a significant investment in Amicus Therapeutics, making it their top holding. They bought 1.48 million shares for $21.2 million, increasing their stake to 1.69 million shares worth $24.4 million. This move comes as Amicus stock surged by 103.7% over the past year, with the company focusing on rare diseases and a potential merger with BioMarin. CIBRAs bet on this merger arbitrage could yield a quick profit or result in significant losses. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bcb74a973709fd69

NOW PLAYING

CIBRA Capital's Big Bet on Amicus Therapeutics

0:00 1:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on April 25, 2026.

What is this episode about?

CIBRA Capitals latest SEC filing reveals a significant investment in Amicus Therapeutics, making it their top holding. They bought 1.48 million shares for $21.2 million, increasing their stake to 1.69 million shares worth $24.4 million. This...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!